Latest Cyclacel Stories
RnRMarketResearch.com adds “Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015” to its store.
CORAL SPRINGS, Florida, March 2, 2015 /PRNewswire/ -- Cutting-edge biotech & nutraceutical products, science-based pharmaceuticals and healthy whole food nutrition
RnRMarketResearch.com adds "Peritoneal Cancer - Pipeline Review, H1 2015" to its store. This provides an overview of the Peritoneal Cancer's therapeutic pipeline. DALLAS, Feb.
RnRMarketResearch.com adds "Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014" to its store.
- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - SAN DIEGO, Jan.
SAN DIEGO, Dec. 22, 2014 /PRNewswire/ -- MEI Pharma, Inc.
BERGEN, Norway, December 15, 2014 /PRNewswire/ -- BerGenBio AS, a biopharmaceutical company focused on developing innovative drugs for aggressive drug resistant cancers,
Company Outlines Plans for Phase III Registration Study San Diego, Dec. 8, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma provides information on pricing, market analysis, shares, forecast, and company
SAN FRANCISCO, Nov.
- An armed gangster.